European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Link

While not always mandatory for final release, tests for Friability (2.9.7) and Resistance to Crushing (2.9.8) are used during production to ensure tablets don't crumble during handling. Recent Regulatory Updates

: Active components are blended with diluents, binders, disintegrating agents, glidants, lubricants, coloring agents, or flavoring agents to ensure structural integrity and stability. Categories of Oral Tablets

: Includes prolonged-release and pulsatile-release tablets designed to alter the rate or timing of drug delivery.

In the pharmaceutical world, the is the gold standard for quality control, and Monograph 0478 is the essential blueprint for anyone manufacturing or testing oral tablets. This general monograph defines exactly what a tablet is and sets the baseline requirements for its production and performance. What is Monograph 0478? European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Understanding Ph. Eur. Monograph 0478: The Standard for Tablets

This test is critical for safety. It ensures that the strength of each individual tablet does not vary significantly from the others. It is performed via two methods:

The , titled "Tablets" (Compressi) , is the central general monograph establishing the mandatory quality standards for all tablet dosage forms in Europe. It provides the legal and scientific framework for their development, production, and marketing. Core Definition & Scope While not always mandatory for final release, tests

(e.g., lozenges, sublingual tablets) Oral lyophilisates 2. Core Production and Manufacturing Requirements

Monograph 0478 defines as solid preparations containing a single dose of one or more active substances, obtained by compressing uniform volumes of particles or by other techniques like extrusion, moulding, or freeze-drying (lyophilisation). It applies primarily to tablets for oral administration but excludes lozenges, oral pastes, and oral gums. In some cases, the requirements may not apply to tablets for veterinary use when justified and authorised.

According to the Ph. Eur., tablets are solid dosage forms containing one or more APIs, compressed into a single unit. Tablets can be coated or uncoated, and may be designed to release the API(s) immediately or over a specified period. In the pharmaceutical world, the is the gold

This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later. Revised Ph. Eur. Chapter Tablets - gmp-compliance.org

"Solid dosage forms each containing a single dose of one or more active substances. They are obtained by compressing uniform volumes of particles or by another suitable manufacturing process, such as extrusion, moulding, or freeze-drying."

The European Pharmacopoeia (Ph. Eur.) monograph for tablets, specifically "Tablets -0478-", provides a detailed framework for evaluating the quality of tablets. The monograph sets out requirements, test methods, and acceptance criteria for tablets, ensuring that medicinal products available to patients in Europe meet the required standards for quality, purity, and strength. By following this monograph, manufacturers, regulators, and control laboratories can ensure that tablets are produced and controlled to a high standard, ultimately contributing to patient safety and public health.

: Manufacturers must take rigorous preventative measures to prevent contamination during processing, storage, and cross-border distribution, adhering directly to the guidelines set in Ph. Eur. General Chapter 5.1 .

: Formulations with fluid or dry-applied polymeric layers, including film-coated varieties.